Exosens

F:H8Y Germany Electrical Equipment & Parts
Market Cap
$3.73 Billion
€3.64 Billion EUR
Market Cap Rank
#5240 Global
#549 in Germany
Share Price
€71.40
Change (1 day)
+7.85%
52-Week Range
€50.70 - €71.40
All Time High
€71.40
About

Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultraviolet, short, medium, and long wave infrared, visible - near infrared, and mid-wave infrared cameras, as well as enhanced vi… Read more

Exosens (H8Y) - Net Assets

Latest net assets as of June 2025: €429.50 Million EUR

Based on the latest financial reports, Exosens (H8Y) has net assets worth €429.50 Million EUR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€867.32 Million) and total liabilities (€437.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €429.50 Million
% of Total Assets 49.52%
Annual Growth Rate 33.83%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 44.02

Exosens - Net Assets Trend (2021–2024)

This chart illustrates how Exosens's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Exosens (2021–2024)

The table below shows the annual net assets of Exosens from 2021 to 2024.

Year Net Assets Change
2024-12-31 €412.60 Million +102.19%
2023-12-31 €204.07 Million +11.48%
2022-12-31 €183.05 Million +6.36%
2021-12-31 €172.11 Million --

Equity Component Analysis

This analysis shows how different components contribute to Exosens's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 14896500000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components €412.60 Million 100.00%
Total Equity €412.60 Million 100.00%

Exosens Competitors by Market Cap

The table below lists competitors of Exosens ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Exosens's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 204,066,000 to 412,600,000, a change of 208,534,000 (102.2%).
  • Net income of 30,700,000 contributed positively to equity growth.
  • Share repurchases of 300,000 reduced equity.
  • New share issuances of 180,000,000 increased equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €30.70 Million +7.44%
Share Repurchases €300.00K -0.07%
Share Issuances €180.00 Million +43.63%
Other Changes €-1.87 Million -0.45%
Total Change €- 102.19%

Book Value vs Market Value Analysis

This analysis compares Exosens's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.78x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 21.07x to 8.78x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 €3.39 €71.40 x
2022-12-31 €3.60 €71.40 x
2023-12-31 €4.02 €71.40 x
2024-12-31 €8.13 €71.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Exosens utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.44%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.79%
  • • Asset Turnover: 0.48x
  • • Equity Multiplier: 1.98x
  • Recent ROE (7.44%) is above the historical average (-15.99%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 -86.55% -89.65% 0.36x 2.68x €-166.18 Million
2022 6.13% 5.59% 0.38x 2.89x €-7.09 Million
2023 9.02% 6.31% 0.44x 3.22x €-2.00 Million
2024 7.44% 7.79% 0.48x 1.98x €-10.56 Million

Industry Comparison

This section compares Exosens's net assets metrics with peer companies in the Electrical Equipment & Parts industry.

Industry Context

  • Industry: Electrical Equipment & Parts
  • Average net assets among peers: $12,018,570,444
  • Average return on equity (ROE) among peers: 3.97%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Exosens (H8Y) €429.50 Million -86.55% 1.02x $1.82 Billion
Leoch International Technology Limited (0LT) $3.27 Billion 4.05% 1.65x $20.63 Million
AB Fagerhult (2F0) $1.63 Billion 23.41% 1.96x $216.55 Million
VPower Group International Holdings Limited (2V3) $3.14 Billion -10.09% 1.84x $15.64 Million
Plejd AB (publ) (3CA) $727.69 Million 24.77% 0.45x $464.11 Million
AQ Group AB (publ) (7AQ0) $3.76 Billion 16.80% 0.58x $1.01 Billion
Prysmian SpA (AEU) $1.51 Billion 14.20% 3.15x $28.75 Billion
Compleo Charging Solutions AG (C0M) $3.95 Million -65.34% 2.17x $303.00K
FRIWO AG (CEA) $13.14 Million 16.56% 2.38x $7.87 Million
Hosiden Corporation (HOD) $94.11 Billion 11.38% 0.42x $702.46 Million